Alumis Inc. Files 8-K for Bylaws and Financials

TL;DR

Alumis Inc. filed an 8-K on July 1, 2024, for corporate updates and financials.

AI Summary

Alumis Inc. filed an 8-K on July 1, 2024, reporting amendments to its Articles of Incorporation or Bylaws and filing financial statements and exhibits. The company, formerly Esker Therapeutics, Inc., is incorporated in Delaware and headquartered in South San Francisco, California.

Why It Matters

This filing indicates routine corporate actions and the submission of financial information, which is standard for public companies to keep investors informed.

Risk Assessment

Risk Level: low — The filing pertains to standard corporate housekeeping and financial reporting, not a significant event like a merger or major financial distress.

Key Numbers

• 001-42143 — SEC File Number (Identifies the company's filing with the SEC)
• 86-1771129 — IRS Employer Identification No. (Company's tax identification number)

Key Players & Entities

• Alumis Inc. (company) — Registrant
• Esker Therapeutics, Inc. (company) — Former company name
• July 1, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• South San Francisco, California (location) — Principal executive offices address

FAQ

Key Financial Figures

• $0.0001 — ge on which registered Common Stock, $0.0001 par value per share ALMS The Nasdaq

Filing Documents

• tm2411163d19_8k.htm (8-K) — 18KB
• tm2411163d19_ex3-1.htm (EX-3.1) — 52KB
• tm2411163d19_ex3-2.htm (EX-3.2) — 194KB
• 0001104659-24-076815.txt ( ) — 266KB

03 Amendments to Articles of Incorporation

Item 5.03 Amendments to Articles of Incorporation or Bylaws Amendment and Restatement of Certificate of Incorporation In connection with the closing of the initial public offering of shares of common stock (the “IPO”) of Alumis Inc. (the “Company”) on July 1, 2024, the Company filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware. The Company’s board of directors (the “Board”) and stockholders previously approved the Restated Certificate to be effective as of immediately following the closing of the IPO. Amendment and Restatement of Bylaws Effective as of July 1, 2024, the Company adopted amended and restated bylaws (the “Restated Bylaws”) in connection with the closing of the IPO. The Board and stockholders previously approved the Restated Bylaws to be effective immediately prior to the closing of the IPO. The foregoing descriptions of the Restated Certificate and Restated Bylaws are qualified in their entirety by reference to the full text of the Restated Certificate and Restated Bylaws, which are filed as Exhibits 3.1 and 3.2 hereto, and are incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d)Exhibits. Exhibit No. Description 3.1 Amended and Restated Certificate of Incorporation of the Registrant. 3.2 Amended and Restated Bylaws of the Registrant.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alumis Inc. By: /s/ Martin Babler Martin Babler President and Chief Executive Officerand Director Dated: July 1, 2024

View Full Filing

View this 8-K filing on SEC EDGAR